Post by
WalkOverTheStrt on Mar 14, 2021 3:14pm
When will
IMO as long as Antibe is on a CA exchange the share price will come no where close to where most biotechs with a PH3 drug are valued ($600M+ minimum of ocurse IMO) let alone one that could reach $4B annual sales....
Dan can talk about waiting for the right time (wind in their sails) but I'd rather have European, USA, Japan, etc. partners signed while on the NASDAQ... market has a short memory and momentum while on the exchange is imperative.
Also any buyout is not going to reach the potential $4B we all hope for unless the stock price is within the typical 60%-100% premium that BoDs approve. No board is going to approve some 200%+ premium, they would be voted out by SHs at next opportunity..
Antibe needs the stock price to appreciate and frankly we are fooling oursleves if we think it will be trading anywhere need there while being on this backwater exchange.
Comment by
123ABC on Mar 14, 2021 4:17pm
In other words, we'll die of old age before this stock does anything.
Comment by
MrMugsy on Mar 14, 2021 4:53pm
Not necessarily. Phase 3 enabling application to be submitted at some point here. Other news to follow as well. Excitement likely to follow as FDA hurdles are jumped and the countdown to P3 begins. IMO
Comment by
123ABC on Mar 15, 2021 7:13am
He definitely seems to be drinking that management Kool-Aid
Comment by
MrMugsy on Mar 15, 2021 9:04am
No - my thoughts - not related to this management or any other management ... except for the experiences I've had. Yes - I have seen success outside the NASDAQ - that is absolutely true. As you will recall, I do want to go to a US exchange - and it will eventually happen.